Third-party lab testing: 3 independent Janoshik assays on file, covering 3 substances, median measured purity 99.8%, most recent test 2025-02-19.
Finnrick, an independent testing programme, publishes 224 assays for Shanghai Sigma Audley SSA: 152 met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation) and 72 did not. Most recent assay 6 May 2026.
Shanghai Sigma Audley SSA listed by Finnrick as "active", has no storefront on record — Finnrick lists only a messaging or social contact. Source: Finnrick, https://www.finnrick.com/vendors/shanghai-sigma-audley-ssa.
Finnrick-tested with failing results. Tested across 13 peptide products with 217 total samples.
Shanghai Sigma Audley SSA is listed as active. Finnrick Grade F. Finnrick avg score: 7/10 across 217 samples (13 products). Failing quality. Not recommended.
Shanghai Sigma Audley SSA holds independent lab grade F, assigned across 217 graded samples, average score 7/10. That grade comes from an independent grader's own sampling, not from PeptideAtlas, and it describes the samples that grader obtained rather than every batch sold.
| Substance | Measured purity | Test date |
|---|---|---|
| Tr30=tirzepatide 30mg | 99.93% | 2025-02-19 |
| Tr20=tirzepatide 20mg | 99.84% | 2025-02-19 |
| Bpc157=bpc157 5mg | 99.75% | 2025-02-18 |
| Product | Assays | Result |
|---|---|---|
| Retatrutide | 82 | 67 passed, 15 failed |
| Tirzepatide | 44 | 35 passed, 9 failed |
| Tesamorelin | 22 | 8 passed, 14 failed |
| BPC-157 | 13 | 3 passed, 10 failed |
| GHK-Cu | 11 | 11 passed, 0 failed |
| Cagrilintide | 10 | 6 passed, 4 failed |
| Semaglutide | 10 | 8 passed, 2 failed |
| Ipamorelin | 8 | 8 passed, 0 failed |
| Sermorelin | 8 | 0 passed, 8 failed |
| PT-141 | 5 | 2 passed, 3 failed |
| CJC-1295 | 4 | 1 passed, 3 failed |
| Melanotan II | 4 | 2 passed, 2 failed |
| TB-500 | 3 | 1 passed, 2 failed |
Source: Finnrick, as published 2026-08-09. Pass and fail are Finnrick's classification against its own threshold, not ours.
| Status | Active |
|---|---|
| Independent lab grade | F (217 samples) |
| Average grader score | 7/10 |
| Independent assays on file | 3 |
| Median measured purity | 99.8% |
| Vendor type | Research-use supplier |
| Satisfaction | 0.4/5 |
|---|---|
| Delivery | 4.2/5 |
| Customer service | 4.4/5 |
| Packaging | 4.8/5 |
| Ease of purchase | 4.9/5 |
| Payment | 4.7/5 |
Scored out of 5 by the same independent grader, from its own buyers rather than from this site.
Shanghai Sigma Audley SSA is listed as active and we hold 3 independent Janoshik assays on file, median measured purity 99.8%; 224 Finnrick assays (152 passing, 72 failing its purity threshold); an independent lab grade of F. That is evidence about the batches that were tested or published, not a guarantee about the vial you receive.
Yes. We hold 3 third-party Janoshik assays for Shanghai Sigma Audley SSA, covering 3 substances, with a median measured purity of 99.8%. The most recent is dated 2025-02-19. Finnrick, an independent testing programme, publishes 224 assays for Shanghai Sigma Audley SSA: 152 met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation) and 72 did not. Most recent assay…
Similar vendors: Nantong Guangyuan Chemical GYC, Qingdao Sigma Chemical QSC, Wuhan Wansheng Biotechnology.
Popular peptides: Semaglutide, Tirzepatide, Retatrutide, BPC-157, CJC-1295, Ipamorelin.
Other reviewed vendors: Shanghai Wibson Biotechnology WBS Peptides Review, Shanghai Yu Si Medical Technology Co Peptides Review, Shanxi Andashihai Technology Peptides Review.